Shelter Pharma Stock Screener | Share Price & Fundamental Analysis
SHELTER
Pharmaceuticals
Screen Shelter Pharma share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹60.01 Cr.
P/B Ratio
1.05
EPS (TTM)
₹6.26
Dividend Yield
-
Debt to Equity
0.02
52W High
-
52W Low
-
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹48.00
Total Equity
₹43.00
Shelter Pharma Share Price History - Stock Screener Chart
Screen SHELTER historical share price movements with interactive charts. Analyze price trends and patterns.
Shelter Pharma Company Profile - Fundamental Screener
Screen Shelter Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SHELTER shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE013V01011
Shelter Pharma Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SHELTER balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 48 | 38 | 21 | 13 | 10 | 11 |
| Current Assets | 33 | 30 | 19 | 10 | 8 | 8 |
| Fixed Assets | 6 | 4 | 2 | 2 | 2 | 2 |
| Liabilities | ||||||
| Total Liabilities | 48 | 38 | 21 | 13 | 10 | 11 |
| Current Liabilities | 1 | 1 | 1 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||
| Total Equity | 43 | 36 | 15 | 9 | 7 | 7 |
| Share Capital | 12 | 12 | 8 | 1 | 1 | 1 |
| Reserves & Surplus | 31 | 24 | 7 | 8 | 7 | 7 |
Screen SHELTER income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 51 | 40 | 36 | 30 | 23 | 30 |
| Expenses | 0 | 41 | 32 | 28 | 27 | 22 | 30 |
| EBITDA | 0 | 10 | 9 | 8 | 3 | 0 | 0 |
| Operating Profit % | 0.00% | 20.00% | 21.00% | 22.00% | 10.00% | 1.00% | 1.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 10 | 8 | 7 | 3 | 0 | 0 |
| Tax | 0 | 2 | 2 | 2 | 1 | 0 | 0 |
| Net Profit | 0 | 7 | 6 | 5 | 2 | 0 | 0 |
| EPS | 0.00 | 6.26 | 5.36 | 6.72 | 42.54 | 0.88 | 1.77 |
Shelter Pharma Cash Flow Screener - Liquidity Fundamentals
Screen SHELTER cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2017-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | 6 | -2 | 0 | 1 | 0 | 0 | 0 |
| Investing Activities | -7 | -4 | 0 | -1 | 0 | 0 | 0 |
| Financing Activities | 0 | 11 | 0 | 0 | 1 | 0 | 0 |
| Net Cash Flow | -2 | 5 | 0 | 0 | 0 | 0 | 0 |
Screen SHELTER shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Aug | 2025-Sept | 2025-Oct | 2025-Nov | 2024-Mar | 2024-Sept | 2023-Aug |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.32% | 52.32% | 52.32% | 46.91% | 47.19% | 56.89% | 54.97% | 56.89% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 43.24% | 42.69% | 42.82% | 49.25% | 49.32% | 30.23% | 40.12% | 29.22% |
| Other Holding | 4.44% | 4.99% | 4.86% | 3.84% | 3.49% | 12.88% | 4.91% | 13.89% |
| Shareholder Count | 1,119 | 1,153 | 1,109 | 1,094 | 1,094 | 836 | 868 | 0 |
Shelter Pharma Dividend Screener - Share Yield Analysis
Screen SHELTER dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Shelter Pharma Index Membership - Market Screener Classification
Screen SHELTER by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Shelter Pharma Market Events Screener - Corporate Actions
Screen SHELTER market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.35 /share | -3.84% | ||
| Annual General Meeting | NA | 1.13% | ||
| Dividend | ₹ 0.33 /share | 2.64% | ||
| Annual General Meeting | NA | -2.22% | ||
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | 0.87% |
| 2025-07-23 | 2025-07-23 | Extraordinary General Meeting | NA | 11.04% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 3.95% |
| 2024-10-30 | 2024-10-30 | Quarterly Result Announcement | NA | 0.58% |
Shelter Pharma Competitors Screener - Peer Comparison
Screen SHELTER competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Shelter Pharma Company Announcements - News Screener
Screen SHELTER latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-01 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-12-31 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-12-12 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Conversion of Securities | View |
| 2025-11-17 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday November 17 2025 Considered And Approved The Conversion Of 735000 Warrants Into 735000 Equity Shares Of Face Value Of Rs. 10/- (Rupees Ten Only) | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-11-15 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday November 15 2025 Considered And Approved The Conversion Of 735000 Warrants Into 735000 Equity Shares Of Face Value Of Rs. 10/- (Rupees Ten Only) | View |
| 2025-11-11 | Intimation With Regards To Shelter Pharma Received ISO 22000:2018 Certification | View |
| 2025-11-10 | Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-10 | Outcome Of The Board Meeting Held On Monday 10 November 2025 And Submission Of The Unaudited Financial Results And Limited Review Report On Financial Result For The Half Year Ended On 30Th September 2025 | View |
| 2025-11-10 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday 10 November 2025 And Submission Of The Unaudited Financial Results And Limited Review Report On Financial Result For The Half Year Ended On 30Th September 2025 | View |
| 2025-11-06 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-11-05 | Board Meeting Intimation for Board Meeting Intimation For Board Meeting To Be Held On 10Th November 2025 | View |
| 2025-11-03 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-10-16 | Announcement under Regulation 30 (LODR)-Conversion of Securities | View |
| 2025-10-16 | Board Meeting Outcome for 861000 Equity Shares Allotted Pursuant To Conversion Of Warrants | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-03 | Announcement under Regulation 30 (LODR)-Conversion of Securities | View |
| 2025-10-03 | Board Meeting Outcome for 1128000 Equity Shares Allotted Pursuant To Conversion Of Fully Paid Warrants. | View |
| 2025-10-01 | Announcement under Regulation 30 (LODR)-Conversion of Securities | View |